'김갑성' 기자의 전체기사
-
Natural Field will Launch "Ashwagandha White Paper" at FTA F…
HANGZHOU, China, Nov. 5, 2025 -- Natural Field, a leading Chinese supplier of botanical and functional ingredients, is set to release its highly anticipated Ashwagandha White Paper at the prestigious Food Technology and Application (FTA) Forum in Hangzhou. The forum, recognized as one of China's foremost platforms for nutrition and health innovation, brings together leading researchers, industry professionals, and enterprise executives to explore cutting-edge technological advances and market trends. Mr. Haiying Yang, founder of Natural Field, will deliver a keynote address highlightin
- 김갑성 기자
- 2025-11-05 23:00
-
Andor Health's Agentic AI Platform, ThinkAndor®, Receives Fro…
[ 메디채널 김갑성 기자 ] Recognized for its transformational innovation and customer impact in driving the evolution of acute care virtual health through advanced, agentic AI-powered collaboration solutions. SAN ANTONIO, Nov. 5, 2025 -- Frost & Sullivan is pleased to announce that Andor Health has received the 2025 North American Transformational Innovation Leadership Recognition in the acute care virtual health industry for its outstanding achievements in transformational innovation and customer impact. This recognition highlights Andor Health's consistent leadership in driving measurabl
- 김갑성 기자
- 2025-11-05 22:30
-
Milliken & Company Recognized with 2025 EcoVadis Gold Ratin…
SPARTANBURG, S.C., Nov. 5, 2025 -- Milliken & Company, a global leader in manufacturing and material science, has earned a gold rating in the 2025 EcoVadis assessment for the fourth consecutive year, placing the company among the top 5% of more than 150,000 organizations evaluated around the world. This achievement marks another milestone in Milliken's ongoing commitment to sustainability, ethical business practices and innovation. "We are proud to have earned a gold rating from EcoVadis for the fourth consecutive year," said Halsey Cook, president and CEO
- 김갑성 기자
- 2025-11-05 21:50
-
BioDlink Congratulates Lepu Biopharma on Securing Approv…
BioDlink helps Lepu Biopharma win China's marketing approval for EGFR-targeted ADC treating recurrent or metastatic nasopharyngeal carcinoma This Becotatug Vedotin injection approval is BioDlink's first commercial ADC manufacturing initiative worldwide, validating its complex biologics commercialization capabilities SUZHOU, China, Nov. 5, 2025 -- BioDlink (1875.HK) congratulates its partner Lepu Biopharma (2157.HK) on receiving conditional marketing approval from China's National Medical Products Administration (NMPA) for MEIYOUHENG (Becotatug Vedotin injection). This Cl
- 김갑성 기자
- 2025-11-05 21:00
-
IDT Biologika Accelerates Global CDMO Expansion Manufactu…
Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune therapeutics Strengthening global CDMO strategy through strategic synergy with SK bioscience Sustainable growth expected, backed by European commercial manufacturing infrastructure and regulatory expertise FRANKFURT, Germany, VIENNA and SEONGNAM, South Korea, Nov. 5, 2025 -- IDT Biologika GmbH (IDT), the European subsidiary of SK bioscience, has embarked on a full-scale drive to expand its global contract development and manufacturing (CDMO) business in vaccines and biopharma
- 김갑성 기자
- 2025-11-05 21:00
-
Nona Biosciences Announces Expansion of Collaboratio…
CAMBRIDGE, Mass., Nov. 5, 2025 -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), today announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR-T cells. This agreement represents an expansion of the strategic collaboration established between the two companies in September 2024. The expanded partnership aims to create multiple in vivo CAR-T cell products by
- 김갑성 기자
- 2025-11-05 20:07
-
HanchorBio Presents Preclinical Data on HCB301 at SITC 2025
[ 메디채널 김갑성 기자 ] HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD-L1, and TGFβ; it shows potent macrophage activation, T-cell restoration, and tumor microenvironment remodeling in preclinical solid tumor models. TAIPEI, SHANGHAI, and SAN FRANCISCO, Nov. 5, 2025 -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced that the preclinical data on HCB301, a novel tri-specific immunotherapeutic fusion protein, has been accepted for prese
- 김갑성 기자
- 2025-11-05 20:00
-
XtalPi Subsidiary Ailux Announces Strategic Collaboration with…
SHANGHAI, Nov. 5, 2025 -- Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a strategic platform-based collaboration with Eli Lilly and Company ("Lilly") to accelerate the discovery and development of bispecific antibodies for the treatment of various diseases. Through this collaboration, Lilly will gain access to Ailux's AI-powered bispecific antibody engineering platform, which integrates advanced structural modeling, generative design, and developability
- 김갑성 기자
- 2025-11-05 18:00
-
SingHealth Duke-NUS Launches Two New Global Health Centr…
The Centre for Global Allied Health and Centre for Global Pharmacy will advance global health collaboration and capacity building, with a focus on strengthening allied health and pharmacy practices across Asia. Both centres build on a legacy of more than 120 global health projects led by SingHealth and Duke-NUS partners, addressing urgent regional healthcare needs driven by ageing populations and rising chronic diseases. SINGAPORE, Nov. 5, 2025 -- The SingHealth Duke-NUS Academic Medical Centre today announced the establishment of two new centres — the Centre for Global
- 김갑성 기자
- 2025-11-05 15:43
-
제5회 세계보건포럼, 기후 변화를 공중보건의 중대 과제로 강조
[ 메디채널 김갑성 기자 ] 베이징 2025년 11월 5일 -- 11월 1일 베이징에서 개최된 제5회 세계보건포럼(World Health Forum)에서 22개 국가 및 지역의 전문가, 학자, 대표 약 400명이 모여 '기후 변화와 보건: 책임, 관리 체계, 그리고 인류의 공동 미래(Climate Change and Health: Responsibility, Governance and a Shared Future for Mankind)'라는 주제로 범세계적 보건 관리 체계를 마련할 방안을 모색했다. 반기문 보아오 아시아 포럼(Boao Forum for Asia) 의장이자 전 유엔(UN) 사무총장은 기조연설에서 기후 변화가 오늘날의 가장 시급한 공중보건 과제임을 강조하고 국제 사회에 기후 변화 대책을 범세계적 최우선 과제로 삼을 것을 촉구했다. 리루밍(Li Luming) 칭화대학교 총장은 인재를 양성하고, 과학 기술 혁신을 증진하며, 국제 협력을 강화하고, 인류 건강과 지속 가능한 발전을 지향하는 더 나은 미래를 한마음, 한뜻으로 보호할 수 있도록 사회 각계각층과 협력하게 되기를 기대한다고 밝혔다. 션훙빙(Shen
- 김갑성 기자
- 2025-11-05 15:15
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-11_THU
- ADI 재단, ADI 체인 메인넷 및 ADI 유틸리티 토큰 출시 02:31
- ADFW's Fintech Abu Dhabi Points to a New Era of Finance Fuelled by Innovation and Disruption 02:02
- カタール博物館のTasweer 、「文化の年（Years of Culture）」の一環として「一つの空の下（Under One Sky）」世界写真公募を発表 00:54
- 카타르 박물관 타스위르, '같은 하늘 아래' 국제 사진 공모전 개최 00:29
2025-12-10_WED
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 11일 04시 00분